Genscript Biotech’s subsidiary Legend Biotech, which agreed to an investment worth nearly $151m from Eli Lilly and Johnson & Johnson last month, has filed to go public.

Qihoo 360-founded Qi An Xin has filed for an initial public offering on China’s Star Market that will provide exits for Red Star Macalline and China Electronics Corporation.

The JD.com and Walmart-backed company is expected to raise as much as $500m in proceeds when it lists on the Nasdaq Global Select Market.

Hua Insurance is in line for a bigger exit as Qingdao Victall Railway oversubscribes its planned initial public offering to raise as much as $172m in proceeds.

Vroom, the AutoNation-backed used car marketplace that completed a $254m series H round last December, has confidentially filed for an initial public offering scheduled for next month.

Kingsoft’s cloud services subsidiary priced shares at the middle of the range but upsized the offering to raise $510m, with shares soaring 27% on the first day of trading.

The mobile payment terminal supplier booked $5.8m from its IPO and is now lining up an acquisition to expand its business.

Kingsoft’s cloud services subsidiary has set its price range for an initial public offering in the US and will raise as much as $450m in proceeds if it floats at the higher end.

Cancer therapy developer Oric, whose backers include Memorial Sloan, Taiho and Hartford HealthCare, floated at the top of its range in an expanded IPO.

The Alibaba-backed e-commerce software and services provider is targeting $61.2m in an initial public offering on the Shanghai Stock Exchange.